Clinical Trial Update: A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind, placebo-controlled, four-period crossover study evaluating the dose-response of fluticasone propionate in allergic rhinitis (i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial, Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2012-09-24